Land: Den Europæiske Union
Sprog: engelsk
Kilde: EMA (European Medicines Agency)
ertapenem sodium
SUN Pharmaceutical Industries (Europe) B.V.
ertapenem
ertapenem
Bacterial Infections
TreatmentErtapenem SUN is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4.4 and 5.1):- Intra-abdominal infections- Community acquired pneumonia- Acute gynaecological infections- Diabetic foot infections of the skin and soft tissue (see section 4.4)PreventionErtapenem SUN is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4.4).Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Authorised
2022-07-15
24 B. PACKAGE LEAFLET 25 PACKAGE LEAFLET: INFORMATION FOR THE USER ERTAPENEM SUN 1 G POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION ertapenem READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU ARE GIVEN THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor, nurse or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Ertapenem SUN is and what it is used for 2. What you need to know before you are given Ertapenem SUN 3. How to use Ertapenem SUN 4. Possible side effects 5. How to store Ertapenem SUN 6. Contents of the pack and other information 1. WHAT ERTAPENEM SUN IS AND WHAT IT IS USED FOR Ertapenem SUN contains ertapenem which is an antibiotic of the beta-lactam group. It has the ability to kill a wide range of bacteria (germs) that cause infections in various parts of the body. Ertapenem SUN can be given to persons 3 months of age and older. Treatment: Your doctor has prescribed Ertapenem SUN because you or your child has one (or more) of the following types of infection: Infection in the abdomen Infection affecting the lungs (pneumonia) Gynaecological infections Skin infections of the foot in diabetic patients. Prevention: Prevention of surgical site infections in adults following surgery of the colon or rectum. 2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN ERTAPENEM SUN DO NOT USE ERTAPENEM SUN - if you are allergic to the active substance (ertapenem) or any of the other ingredients of this medicine (listed in section 6) - if you are allergic to antibiotics such as penicillins, cephalosporins or carbapenems (which are used to treat various infections). WARNINGS AND PRECAUTIONS Talk to Læs hele dokumentet
1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 2 1. NAME OF THE MEDICINAL PRODUCT Ertapenem SUN 1 g powder for concentrate for solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 1 g ertapenem. After reconstitution, the vial contains concentrate of approximately 100 mg/ml. Excipient(s) with known effect Each 1 g dose contains approximately 6.87 mEq of sodium (approximately 158 mg). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Powder for concentrate for solution for infusion. Off-white to pale yellow powder. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment Ertapenem SUN is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4.4 and 5.1): Intra-abdominal infections Community acquired pneumonia Acute gynaecological infections Diabetic foot infections of the skin and soft tissue (see section 4.4) Prevention Ertapenem SUN is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4.4). Consideration should be given to official guidance on the appropriate use of antibacterial agents. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Intravenous use. _Treatment_ _Adults and adolescents (13 to 17 years of age)_ : The dose of Ertapenem SUN is 1 gram (g) given once a day, see section 6.6. _Infants and children (3 months to 12 years of age)_ : The dose of Ertapenem SUN is 15 mg/kg given twice daily (not to exceed 1 g/day), see section 6.6. 3 _Prevention_ _Adults: _ To prevent surgical site infections following elective colorectal surgery, the recommended dose is 1 g administered as a single intravenous dose to be completed within 1 hour prior to the surgical incision. _Paediatric population _ The safety and efficacy of Ertapenem SUN in children below 3 months of age have not yet Læs hele dokumentet